化疗诱导的缓解症的多样性
Leah J Novinger1,2, Natalia M Weinzierl1, Andrea Bonetto1,2
1Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
American journal of physiology. Cell physiology
|December 5, 2024
概括
化疗可以导致癌症缓解症,导致肌肉消耗. 本综述探讨了不同的药物,癌症,年龄和性别如何影响化疗诱导的缓解症的发展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 老年学是一门学科.
背景情况:
- 化疗药物如多克索鲁比辛,福尔菲里和西斯普拉丁可以诱导骨肌肉的消耗和软弱,称为缓解症.
- 癌症缓解症的特点是肌肉缩,蛋白质分解和线粒体功能障碍,不同药物之间的分子路径变化.
- 肌肉消耗可能在癌症治疗期间发生早期并持续,影响患有各种恶性瘤的患者,包括胃肠道,头和非小细胞肺癌.
研究的目的:
- 为了检查化疗诱导的缓解症的多样性.
- 根据特定的化疗方案,癌症类型,患者年龄和性别,探索缓解症发展的差异.
主要方法:
- 对化学疗法诱导的缓解症进行的临床前和临床研究的综述.
- 分析因多克索鲁比,福尔菲里和西斯普拉丁诱导的缓冲症的共同点和区分特征.
- 检查卡赫克西亚发作和进展的年龄和性别相关差异.
主要成果:
- 化疗方案,癌症类型,年龄和性别都是影响癌症缓解症的发展和表现的因素.
- 临床前研究通常使用年轻的模型,而临床研究则专注于老年患者,突出了理解与年龄相关影响的差距.
- 在化疗诱导的缓解症中观察到性别差异,这表明潜在的性别特异性治疗策略.
结论:
- 化疗诱导的缓解症是一种复杂的疾病,具有多种表现.
- 需要进一步的研究,以了解不同化疗,癌症,年龄和性别对缓冲症的具体影响.
- 根据患者特定因素 (如年龄和性别) 量身定制的缓解症治疗可能会改善结果.
更多相关视频
07:54Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
18.6K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
10.9K
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
174
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
174
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
224
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
224
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
201
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
201